Jeff Craven April 27, 2023 CORRECTED May 4, 2023 // Editor’s Note: An earlier version of this article misstated the percentage of COVID-positive patients in the study population. BOSTON – Atogepant helped reduce the number of mean migraine days among adults with episodic migraine who failed multiple other oral migraine medications, according to findings from a study presented at the 2023 annual meeting of the...
Tag: <span>Atogepant</span>
Post
Atogepant prevents migraine in adults
Atogepant appears to be effective and well tolerated for the preventive treatment of migraine, according to a study published online June 8 in JAMA Network Open. Richard B. Lipton, M.D., from Albert Einstein College of Medicine and the Montefiore Headache Center in New York City, and colleagues evaluated the efficacy and safety of atogepant for the preventive treatment...